Initiation of Protein Synthesis by a Labeled Derivative of theLactobacillus caseiDN-114 001 Strain during Transit from the Stomach to the Cecum in Mice Harboring Human Microbiota
Open Access
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 70 (12) , 6992-6997
- https://doi.org/10.1128/aem.70.12.6992-6997.2004
Abstract
Although studies on the survival of bacteria in the digestive tract have been reported in the literature, little data are available on the physiological adaptation of probiotics to the digestive environment. In previous work, a transcriptional fusion system (i.e., luciferase genes under the control of a deregulated promoter) was used to demonstrate that a derivative of theLactobacillus caseiDN-114 001 strain, ingested in a fermented milk and thus exhibiting initially a very weak metabolic activity, synthesized proteins de novo after its transit in the digestive tract of mice harboring human microbiota (known as human-microbiota-associated mice). With the same genetic system and animal model, we here investigate for the first time the ability ofL. caseito reinitiate synthesis in the different digestive tract compartments. In this study, most ingestedL. caseicells transited from the stomach to the duodenum-jejunum within 1 h postingestion. No luciferase activity was observed in these digestive tract compartments after the first hour. At later times, the bulk of bacteria had transited to the ileum and the cecum. Luciferase synthesis was detected between 1.5 and 2.0 h postingestion at the ileal level and from 1.5 h to at least 6.0 h postingestion in the cecum, where the activity remained at a maximum level. These results demonstrate that ingestedL. casei(derivative of the DN-114 001 strain) administered via a fermented milk has already reinitiated protein synthesis when it reaches the ileal and cecal compartments.Keywords
This publication has 22 references indexed in Scilit:
- Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteriaGut, 2002
- Lactobacillus caseiIs Able To Survive and Initiate Protein Synthesis during Its Transit in the Digestive Tract of Human Flora-Associated MiceApplied and Environmental Microbiology, 2002
- Lactococcus lactis, A Tool for the Delivery of Therapeutic Proteins Treatment of IBDThe Scientific World Journal, 2001
- Monitoring and Survival of Lactobacillus paracasei LTH 2579 in Food and the Human Intestinal TractSystematic and Applied Microbiology, 2000
- Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tractAlimentary Pharmacology & Therapeutics, 2000
- Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp.Immunology & Cell Biology, 2000
- ProbioticsInternational Journal of Food Microbiology, 1998
- Potential of using lactic acid bacteria for therapy and immunomodulation in manFEMS Microbiology Reviews, 1993
- Probiotics in human medicine.Gut, 1991
- A MEDIUM FOR THE CULTIVATION OF LACTOBACILLIJournal of Applied Bacteriology, 1960